1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
63056370499BCE1A685257EC800693D0A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/document-excerpt-best-practices-globalizing-msl-field-based-medical-specialist-programs-structure-operating-models?opendocument
18
19opendocument
203.215.79.204
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Field Medical Excellence

Document Excerpt: Best Practices in Globalizing MSL & Field-Based Medical Specialist Programs: Structure and Operating Models

DB Image

ID: MD-484


Features:

17 Info Graphics

12 Data Graphics

128 Metrics

6 Narratives


Pages/Slides: 38


Published: Pre-2017


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "Buy Now" on the right.

To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5383 "Best Practices in Globalizing MSL & Field-Based Medical Specialist Programs: Structure and Operating Models".


Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Chemical; Clinical Research; Laboratories


Companies Profiled:
Abbvie; Reliance Life Sciences; Alkermes; Almirall; AstraZeneca; BARD; Baxalta; Baxter Healthcare; Bayer; Biogen; Boehringer Ingelheim; Eisai; Genentech; Janssen; LEO Pharma; Lundbeck; Medivation; Medtronic; Merck; Novartis; Novo Nordisk; Pfizer; Pierre Fabre Medicament; ProStrakan; Roche; Sanofi; Santen; Sunovion; Teva Pharmaceutical Industries Ltd; The Medicines Company; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.